CoQ10 (Ubiquinol) 200mg Cuts Gum Bleeding -42%, Pocket Depth -1.5mm in 12-Week Periodontitis RCT
WELLNESS

CoQ10 (Ubiquinol) 200mg Cuts Gum Bleeding -42%, Pocket Depth -1.5mm in 12-Week Periodontitis RCT

By Claire · · Journal of Periodontology 2025
KO | EN

Coenzyme Q10 (ubiquinol, reduced active form) 200mg/day for 12 weeks reduced gum bleeding -42%, pocket depth -1.5mm, gingival index (GI) -38%, periodontal pathogenic bacteria (P. gingivalis·T. forsythia) -32%, gum tissue oxidative stress -28% in 180 chronic periodontitis patients, according to 2025 Journal of Periodontology data. First RCT validation for gum mitochondrial energy·antioxidant recovery as periodontitis target.

The trial enrolled 180 chronic periodontitis (stage II~III) patients across 12 weeks. Results: bleeding on probing (BOP) -42%, pocket depth (PD) -1.5mm average reduction, gingival index (GI) -38%, periodontal pathogens -32%, gum tissue oxidative stress markers -28%, antioxidant capacity (SOD·GSH) +25%, clinical attachment level (CAL) +1.2mm. Adverse events: minor (mild gastric 4%).

CoQ10 — gum mitochondrial recovery

Gums and mitochondria:

  • Gum tissue requires high energy (ATP) for rapid turnover
  • Collagen·protein synthesis, immune cell activity, bacterial defense
  • Oxidative stress ↑ + mitochondrial dysfunction → periodontitis progression

CoQ10 (ubiquinol) — core molecule:

  • Mitochondrial electron transport chain (ETC) core
  • ATP synthesis support
  • Potent antioxidant (lipid·protein·DNA protection)
  • Reduced form (ubiquinol) absorbs better than oxidized (ubiquinone)

Why periodontitis target:

  • Periodontitis gum tissue CoQ10 levels -50~70% reduction
  • Mitochondrial dysfunction → gum tissue recovery ↓
  • Oxidative stress ↑ → chronic inflammation perpetuated
  • Antibiotics·mechanical cleaning insufficient → CoQ10 adjunct

Multi-target mechanisms:

1. Gum mitochondrial ATP +25%:

  • ATP ↑ → collagen synthesis·immune cell activity
  • Gum tissue recovery acceleration

2. Bleeding on probing (BOP) -42%:

  • Oxidative stress ↓ → capillary fragility protection
  • Inflammation ↓ → bleeding reduction
  • Brushing·flossing bleeding reduced

3. Pocket depth (PD) -1.5mm:

  • Gum tissue attachment recovery
  • Periodontal pocket depth reduction
  • Bacterial habitat ↓

4. Periodontal pathogens -32%:

  • P. gingivalis·T. forsythia·T. denticola
  • Gum immunity ↑ → bacterial control
  • Antibiotic adjunct

5. Antioxidant +25%:

  • SOD (superoxide dismutase)·GSH (glutathione) ↑
  • Gum tissue oxidative damage ↓
  • Chronic inflammation block

Clinical data

  • Journal of Periodontology 2025 RCT 180 patients 12 weeks: BOP -42%, PD -1.5mm
  • 2024 trial: post-periodontal surgery recovery 100 patients 8 weeks attachment level +25%
  • 2023 trial: diabetes + periodontitis 80 patients 12 weeks BOP -38%, HbA1c -0.5%
  • 2022 trial: chronic periodontitis 60 patients 6 months CoQ10 + vitamin E matrix superior
  • 2024 meta-analysis: 14 CoQ10 periodontitis trials consistent efficacy
  • 1970s first periodontitis adjunct trial (50-year cumulative)

Korean market context

Supplements:

  • Ubiquinol 100mg 60 caps: 30,000~60,000 KRW
  • Ubiquinol 200mg 60 caps: 50,000~100,000 KRW
  • Ubiquinone (cheaper) 60 caps: 15,000~30,000 KRW
  • Matrix (CoQ10 + vitamin K2 + D3) 60 caps: 60,000~120,000 KRW

Use:

  • Gum·cardiovascular target: 100~200mg/day ubiquinol
  • With meals (fat-soluble, absorption ↑)
  • 12-week cumulative assessment
  • 50+ natural decline target

Diet — natural CoQ10:

  • Beef·pork (especially heart·liver)
  • Sardines·mackerel (naturally rich)
  • Spinach·broccoli·cauliflower
  • Nuts (peanuts·sesame)
  • Brown rice·whole wheat

Topical adjunct:

  • CoQ10 toners·toothpaste·gum gel
  • Oral + topical matrix

Cautions

  • Anticoagulant warfarin: CoQ10 may weaken warfarin effect. Physician assessment (INR tracking)
  • Cancer chemotherapy: some drug effect impacts possible. Physician assessment
  • Hypoglycemic agents: CoQ10 supports glucose control → hypoglycemia risk
  • Blood pressure medications: slight BP ↓ possible. Physician assessment
  • Pregnancy·lactation: limited safety data, physician assessment
  • Ubiquinol vs ubiquinone: 50+·liver dysfunction prefer ubiquinol (conversion capacity ↓)
  • 3-month cumulative assessment: gum·mitochondrial recovery cumulative
  • Periodontal treatment + adjunct: not a replacement for antibiotics·mechanical cleaning

Synergy matrix

  • CoQ10 + vitamin K2 + D3: gum·tooth matrix
  • + Vitamin E + selenium: antioxidant matrix
  • + Xylitol: cavity matrix
  • + Propolis: oral antimicrobial matrix
  • + Lactobacillus reuteri: oral probiotic matrix
  • + Periodontal treatment (scaling·antibiotics): medical adjunct matrix

Consumer message

Gum bleeding·swelling·periodontitis signal gum mitochondrial·antioxidant dysfunction. CoQ10 (ubiquinol) 200mg/day 12-week cumulative gains: gum bleeding -42%, pocket depth -1.5mm, periodontal bacteria -32%, antioxidant +25%. 50+ gum CoQ10 levels -5070% natural decline. Ubiquinol (reduced form) absorption superior, with meals. 30,000100,000 KRW/60 caps. Caveats: warfarin·diabetic·pregnancy physician assessment, periodontal treatment + adjunct (not replacement). Pairs with vitamin K2·D3·E + xylitol·propolis·oral probiotics matrix. Beef·sardines·spinach natural assets. Spring 2026 oral·periodontal matrix.